Enantioselective Synthesis of Dioxatriquinane Structural Motifs for HIV-1 Protease Inhibitors Using a Cascade Radical Cyclization

about

Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS Photoinduced Cycloadditions in the Diversity-Oriented Synthesis Toolbox: Increasing Complexity with Straightforward Postphotochemical Modifications.

P2860

Q38708006-37BBE516-C194-46F8-B5B1-05B3B0BBD85D Q47115782-DA03FC82-F104-4612-872A-1A244C3F6F90

P2860

Enantioselective Synthesis of Dioxatriquinane Structural Motifs for HIV-1 Protease Inhibitors Using a Cascade Radical Cyclization

Item

http://www.wikidata.org/entity/Q35846634

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Enantioselective Synthesis of ...... a Cascade Radical Cyclization

@ast

Enantioselective Synthesis of ...... a Cascade Radical Cyclization

@en

type

Item

label

Enantioselective Synthesis of ...... a Cascade Radical Cyclization

@ast

Enantioselective Synthesis of ...... a Cascade Radical Cyclization

@en

prefLabel

Enantioselective Synthesis of ...... a Cascade Radical Cyclization

@ast

Enantioselective Synthesis of ...... a Cascade Radical Cyclization

@en

P1476

Enantioselective Synthesis of ...... a Cascade Radical Cyclization

@en

P2093

Arun K Ghosh

http://www.w3.org/2001/XMLSchema#string

Chun-Xiao Xu

http://www.w3.org/2001/XMLSchema#string

Heather L Osswald

http://www.w3.org/2001/XMLSchema#string

P2860

AIDS — The First 20 Years

Darunavir, a conceptually new HIV-1 protease inhibitor for the treatment of drug-resistant HIV

Probing Multidrug-Resistance and Protein-Ligand Interactions with Oxatricyclic Designed Ligands in HIV-1 Protease Inhibitors

Novel P2 Tris-tetrahydrofuran Group in Antiviral Compound 1 (GRL-0519) Fills the S2 Binding Pocket of Selected Mutants of HIV-1 Protease

Highly Potent HIV-1 Protease Inhibitors with Novel Tricyclic P2 Ligands: Design, Synthesis, and Protein–Ligand X-ray Studies

A potent human immunodeficiency virus type 1 protease inhibitor, UIC-94003 (TMC-126), and selection of a novel (A28S) mutation in the protease active site.

Novel bis-tetrahydrofuranylurethane-containing nonpeptidic protease inhibitor (PI) UIC-94017 (TMC114) with potent activity against multi-PI-resistant human immunodeficiency virus in vitro.

Bis-tetrahydrofuran: a privileged ligand for darunavir and a new generation of hiv protease inhibitors that combat drug resistance.

GRL-0519, a novel oxatricyclic ligand-containing nonpeptidic HIV-1 protease inhibitor (PI), potently suppresses replication of a wide spectrum of multi-PI-resistant HIV-1 variants in vitro.

Why do patients fail HIV therapy?

P304

3314-3317

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.TETLET.2015.01.019

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26185337

http://www.w3.org/2001/XMLSchema#string

P921

enantioselectivity

P932

4500529

http://www.w3.org/2001/XMLSchema#string

Enantioselective Synthesis of Dioxatriquinane Structural Motifs for HIV-1 Protease Inhibitors Using a Cascade Radical Cyclization

about

P2860

P2860

Enantioselective Synthesis of Dioxatriquinane Structural Motifs for HIV-1 Protease Inhibitors Using a Cascade Radical Cyclization

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932